companydata.dkcompanydata.dk

BACH BOLIGCENTER ApS: Financial statements 2022

CVR: 12024584

Source: annual report 2022, Danish Business Authority

01/05/2021 – 30/04/2022

BACH BOLIGCENTER ApS (CVR 12024584) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -13,574 and a net result of DKK -153,237 compared with DKK -8,961 the year before. Equity in the 2022 report amounted to DKK 682,284. The solvency ratio was 97.1%. The company had 1 employee in the financial year.

Gross Profit
DKK -13,574
Profit/Loss
DKK -153,237
Equity
DKK 682,284
Total Assets
DKK 702,561
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022--14K-153K682K1
2021--13K-9K892K1
2020--14K-166K956K0
2019--17K12K1.2M1
2018--18K9K1.2M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on BACH BOLIGCENTER ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

About BACH BOLIGCENTER ApS

BACH BOLIGCENTER ApS is a Danish company of the type Anpartsselskab based in Hammel, founded in 1988. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named EMBRYODAN ApS. The management consists of Geo Koch. The company is owned by Geo Koch. The company has 1 employee (2023). In 2026, the company reported a gross profit of DKK -12,635 and a net result of DKK 3,958 compared with DKK -35,885 the year before. Equity in the 2026 report amounted to DKK 243,122.

Source: annual report 2026, Danish Business Authority